| Independent Reports (Showing 1 to 10 of 12) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 8-Feb-10 | PriceTarget Research, Inc. | N/A | Alexza Pharmactcls has a current Overall Rating of D (Negative). | 7 | $25 | View Abstract |
| 5-Feb-10 | Ford Investor Services, Inc. | N/A | Value Graph: ALEXZA PHARMACEU -- ALXA | 1 | $4 | View Abstract |
| 5-Feb-10 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ALXA , ALTH , ARIA , CORX , DEPO , ISTA , PTIE , QCOR -- DRUGS | 3 | $4 | View Abstract |
| 4-Feb-10 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Alexza Pharmaceuticals, Inc. | 40 | $65 | View Abstract |
| 2-Feb-10 | EconomicInvestor | N/A | "The Economy Matters" Report for ALXA: the economy's impact on ALXA's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 | $15 | View Abstract |
| 6-Jan-10 | Global Markets Direct | Global Markets Direct | Alexza Pharmaceuticals, Inc. Financial and Strategic Analysis Review | 37 | $300 | View Abstract |
| 30-Mar-09 | Pechala's Reports | Lubomir Pechala | ALEXZA PHARMACEUTICALS INC (ALXA=US) - REPORT FOR ACTIVE TRADERS | 4 | $25 | View Abstract |
| 30-Mar-09 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for DRUGS | 18 | $49 | View Abstract |
| 30-Mar-09 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for ALXA | 13 | $25 | View Abstract |
| 28-Mar-09 | Pechala's Reports | Frantisek Pechala | ALEXZA PHARMACEUTICALS INC (ALXA=US) 12-months forecast | 1 | $15 | View Abstract |